Loading…
Direct selection of binding proficient/catalytic deficient variants of BamHI endonuclease
Variants of BamHI endonuclease in which the glutamate 113 residue has been changed to lysine or the aspartate 94 to asparagine were shown to behave as repressor molecules in vivo. This was demonstrated by placing a BamHI recognition sequence, GGATCC, positioned as an operator sequence in an antlsens...
Saved in:
Published in: | Nucleic acids research 1994-03, Vol.22 (6), p.1068-1074 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 1074 |
container_issue | 6 |
container_start_page | 1068 |
container_title | Nucleic acids research |
container_volume | 22 |
creator | Dorner, Lydia F. Schildkraut, Ira |
description | Variants of BamHI endonuclease in which the glutamate 113 residue has been changed to lysine or the aspartate 94 to asparagine were shown to behave as repressor molecules in vivo. This was demonstrated by placing a BamHI recognition sequence, GGATCC, positioned as an operator sequence in an antlsense promoter for the aadA gene (spectinomycin resistance). Repression of this promoter relieved the inhibition of expression of spectinomycin resistance. This system was then used to select new binding proficient/cleavage deficient BamHI variants. The BamHI endonuclease gene was mutagenized either by exposure to hydroxylamine or by PCR. The mutagenized DNA was reintroduced into E.coil carrying the aadA gene construct, and trartsformants that conferred spectinomycin resistance were selected. Twenty Spr transformants were sequenced. Thirteen of these were newly isolated variants of the previously identified D94 and E113 residues which are known to be involved in catalysis. The remaining seven variants were all located at residue 111 and the glutamate 111 residue was shown to be involved with catalysis. |
doi_str_mv | 10.1093/nar/22.6.1068 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_307931</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16807907</sourcerecordid><originalsourceid>FETCH-LOGICAL-i389t-57c850135867dbf7917eb3286ca54af33b76b8eb5d2138d6558aeae3a233fbb23</originalsourceid><addsrcrecordid>eNqFkL1vFDEQxS1EFI6EkhJpC0S3OXtn_VVQkITkIoWQAiSgscZebzDseS_2XkT--zjK6gQV1Wjm_d7ozRDymtEjRjUsI6Zl0xyJ0gn1jCwYiKZutWiekwUFymtGW_WCvMz5F6WsZbzdJ_tSUyVBL8j305C8m6rsh1LCGKuxr2yIXYg31SaNfXDBx2npcMLhfgqu6vw8q-4wBYxTfrQc43p1UfnYjXHrBo_ZH5K9HofsX831gHw9-_jlZFVffj6_OPlwWQdQeqq5dIpTBlwJ2dleaia9hUYJh7zFHsBKYZW3vGsYqE5wrtCjB2wAemsbOCDvn_ZutnbtO1eSJRzMJoU1pnszYjD_KjH8NDfjnQEqNbDifzf703i79Xky65CdHwaMftxmwzRwLiX8HxSqbKSygG_-TrSLMj-96G9nHbPDoU8YXcg7DLQsl_KC1U9YyJP_s5Mx_TZCguRm9e2H-XS9Oju-OgVzBQ92dKGn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16807907</pqid></control><display><type>article</type><title>Direct selection of binding proficient/catalytic deficient variants of BamHI endonuclease</title><source>PubMed Central (Open Access)</source><source>Oxford University Press Archive</source><creator>Dorner, Lydia F. ; Schildkraut, Ira</creator><creatorcontrib>Dorner, Lydia F. ; Schildkraut, Ira</creatorcontrib><description>Variants of BamHI endonuclease in which the glutamate 113 residue has been changed to lysine or the aspartate 94 to asparagine were shown to behave as repressor molecules in vivo. This was demonstrated by placing a BamHI recognition sequence, GGATCC, positioned as an operator sequence in an antlsense promoter for the aadA gene (spectinomycin resistance). Repression of this promoter relieved the inhibition of expression of spectinomycin resistance. This system was then used to select new binding proficient/cleavage deficient BamHI variants. The BamHI endonuclease gene was mutagenized either by exposure to hydroxylamine or by PCR. The mutagenized DNA was reintroduced into E.coil carrying the aadA gene construct, and trartsformants that conferred spectinomycin resistance were selected. Twenty Spr transformants were sequenced. Thirteen of these were newly isolated variants of the previously identified D94 and E113 residues which are known to be involved in catalysis. The remaining seven variants were all located at residue 111 and the glutamate 111 residue was shown to be involved with catalysis.</description><identifier>ISSN: 0305-1048</identifier><identifier>EISSN: 1362-4962</identifier><identifier>DOI: 10.1093/nar/22.6.1068</identifier><identifier>PMID: 7908739</identifier><identifier>CODEN: NARHAD</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Analytical, structural and metabolic biochemistry ; Aspartic Acid ; Base Sequence ; Binding Sites ; Biological and medical sciences ; Catalysis ; Deoxyribonuclease BamHI - chemistry ; Deoxyribonuclease BamHI - genetics ; Deoxyribonuclease BamHI - metabolism ; DNA - drug effects ; Drug Resistance ; Enzymes and enzyme inhibitors ; Escherichia coli ; Fundamental and applied biological sciences. Psychology ; Glutamates ; Glutamic Acid ; Hydrolases ; Hydroxylamine ; Hydroxylamines - pharmacology ; Molecular Sequence Data ; Mutagenesis ; Plasmids ; Polymerase Chain Reaction ; Promoter Regions, Genetic ; Repressor Proteins ; Sequence Analysis ; Spectinomycin - pharmacology</subject><ispartof>Nucleic acids research, 1994-03, Vol.22 (6), p.1068-1074</ispartof><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC307931/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC307931/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3971385$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7908739$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dorner, Lydia F.</creatorcontrib><creatorcontrib>Schildkraut, Ira</creatorcontrib><title>Direct selection of binding proficient/catalytic deficient variants of BamHI endonuclease</title><title>Nucleic acids research</title><addtitle>Nucleic Acids Res</addtitle><description>Variants of BamHI endonuclease in which the glutamate 113 residue has been changed to lysine or the aspartate 94 to asparagine were shown to behave as repressor molecules in vivo. This was demonstrated by placing a BamHI recognition sequence, GGATCC, positioned as an operator sequence in an antlsense promoter for the aadA gene (spectinomycin resistance). Repression of this promoter relieved the inhibition of expression of spectinomycin resistance. This system was then used to select new binding proficient/cleavage deficient BamHI variants. The BamHI endonuclease gene was mutagenized either by exposure to hydroxylamine or by PCR. The mutagenized DNA was reintroduced into E.coil carrying the aadA gene construct, and trartsformants that conferred spectinomycin resistance were selected. Twenty Spr transformants were sequenced. Thirteen of these were newly isolated variants of the previously identified D94 and E113 residues which are known to be involved in catalysis. The remaining seven variants were all located at residue 111 and the glutamate 111 residue was shown to be involved with catalysis.</description><subject>Analytical, structural and metabolic biochemistry</subject><subject>Aspartic Acid</subject><subject>Base Sequence</subject><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>Catalysis</subject><subject>Deoxyribonuclease BamHI - chemistry</subject><subject>Deoxyribonuclease BamHI - genetics</subject><subject>Deoxyribonuclease BamHI - metabolism</subject><subject>DNA - drug effects</subject><subject>Drug Resistance</subject><subject>Enzymes and enzyme inhibitors</subject><subject>Escherichia coli</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Glutamates</subject><subject>Glutamic Acid</subject><subject>Hydrolases</subject><subject>Hydroxylamine</subject><subject>Hydroxylamines - pharmacology</subject><subject>Molecular Sequence Data</subject><subject>Mutagenesis</subject><subject>Plasmids</subject><subject>Polymerase Chain Reaction</subject><subject>Promoter Regions, Genetic</subject><subject>Repressor Proteins</subject><subject>Sequence Analysis</subject><subject>Spectinomycin - pharmacology</subject><issn>0305-1048</issn><issn>1362-4962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNqFkL1vFDEQxS1EFI6EkhJpC0S3OXtn_VVQkITkIoWQAiSgscZebzDseS_2XkT--zjK6gQV1Wjm_d7ozRDymtEjRjUsI6Zl0xyJ0gn1jCwYiKZutWiekwUFymtGW_WCvMz5F6WsZbzdJ_tSUyVBL8j305C8m6rsh1LCGKuxr2yIXYg31SaNfXDBx2npcMLhfgqu6vw8q-4wBYxTfrQc43p1UfnYjXHrBo_ZH5K9HofsX831gHw9-_jlZFVffj6_OPlwWQdQeqq5dIpTBlwJ2dleaia9hUYJh7zFHsBKYZW3vGsYqE5wrtCjB2wAemsbOCDvn_ZutnbtO1eSJRzMJoU1pnszYjD_KjH8NDfjnQEqNbDifzf703i79Xky65CdHwaMftxmwzRwLiX8HxSqbKSygG_-TrSLMj-96G9nHbPDoU8YXcg7DLQsl_KC1U9YyJP_s5Mx_TZCguRm9e2H-XS9Oju-OgVzBQ92dKGn</recordid><startdate>19940325</startdate><enddate>19940325</enddate><creator>Dorner, Lydia F.</creator><creator>Schildkraut, Ira</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7TM</scope><scope>5PM</scope></search><sort><creationdate>19940325</creationdate><title>Direct selection of binding proficient/catalytic deficient variants of BamHI endonuclease</title><author>Dorner, Lydia F. ; Schildkraut, Ira</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i389t-57c850135867dbf7917eb3286ca54af33b76b8eb5d2138d6558aeae3a233fbb23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Analytical, structural and metabolic biochemistry</topic><topic>Aspartic Acid</topic><topic>Base Sequence</topic><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>Catalysis</topic><topic>Deoxyribonuclease BamHI - chemistry</topic><topic>Deoxyribonuclease BamHI - genetics</topic><topic>Deoxyribonuclease BamHI - metabolism</topic><topic>DNA - drug effects</topic><topic>Drug Resistance</topic><topic>Enzymes and enzyme inhibitors</topic><topic>Escherichia coli</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Glutamates</topic><topic>Glutamic Acid</topic><topic>Hydrolases</topic><topic>Hydroxylamine</topic><topic>Hydroxylamines - pharmacology</topic><topic>Molecular Sequence Data</topic><topic>Mutagenesis</topic><topic>Plasmids</topic><topic>Polymerase Chain Reaction</topic><topic>Promoter Regions, Genetic</topic><topic>Repressor Proteins</topic><topic>Sequence Analysis</topic><topic>Spectinomycin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dorner, Lydia F.</creatorcontrib><creatorcontrib>Schildkraut, Ira</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Nucleic Acids Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nucleic acids research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dorner, Lydia F.</au><au>Schildkraut, Ira</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct selection of binding proficient/catalytic deficient variants of BamHI endonuclease</atitle><jtitle>Nucleic acids research</jtitle><addtitle>Nucleic Acids Res</addtitle><date>1994-03-25</date><risdate>1994</risdate><volume>22</volume><issue>6</issue><spage>1068</spage><epage>1074</epage><pages>1068-1074</pages><issn>0305-1048</issn><eissn>1362-4962</eissn><coden>NARHAD</coden><abstract>Variants of BamHI endonuclease in which the glutamate 113 residue has been changed to lysine or the aspartate 94 to asparagine were shown to behave as repressor molecules in vivo. This was demonstrated by placing a BamHI recognition sequence, GGATCC, positioned as an operator sequence in an antlsense promoter for the aadA gene (spectinomycin resistance). Repression of this promoter relieved the inhibition of expression of spectinomycin resistance. This system was then used to select new binding proficient/cleavage deficient BamHI variants. The BamHI endonuclease gene was mutagenized either by exposure to hydroxylamine or by PCR. The mutagenized DNA was reintroduced into E.coil carrying the aadA gene construct, and trartsformants that conferred spectinomycin resistance were selected. Twenty Spr transformants were sequenced. Thirteen of these were newly isolated variants of the previously identified D94 and E113 residues which are known to be involved in catalysis. The remaining seven variants were all located at residue 111 and the glutamate 111 residue was shown to be involved with catalysis.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>7908739</pmid><doi>10.1093/nar/22.6.1068</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0305-1048 |
ispartof | Nucleic acids research, 1994-03, Vol.22 (6), p.1068-1074 |
issn | 0305-1048 1362-4962 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_307931 |
source | PubMed Central (Open Access); Oxford University Press Archive |
subjects | Analytical, structural and metabolic biochemistry Aspartic Acid Base Sequence Binding Sites Biological and medical sciences Catalysis Deoxyribonuclease BamHI - chemistry Deoxyribonuclease BamHI - genetics Deoxyribonuclease BamHI - metabolism DNA - drug effects Drug Resistance Enzymes and enzyme inhibitors Escherichia coli Fundamental and applied biological sciences. Psychology Glutamates Glutamic Acid Hydrolases Hydroxylamine Hydroxylamines - pharmacology Molecular Sequence Data Mutagenesis Plasmids Polymerase Chain Reaction Promoter Regions, Genetic Repressor Proteins Sequence Analysis Spectinomycin - pharmacology |
title | Direct selection of binding proficient/catalytic deficient variants of BamHI endonuclease |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A05%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct%20selection%20of%20binding%20proficient/catalytic%20deficient%20variants%20of%20BamHI%20endonuclease&rft.jtitle=Nucleic%20acids%20research&rft.au=Dorner,%20Lydia%20F.&rft.date=1994-03-25&rft.volume=22&rft.issue=6&rft.spage=1068&rft.epage=1074&rft.pages=1068-1074&rft.issn=0305-1048&rft.eissn=1362-4962&rft.coden=NARHAD&rft_id=info:doi/10.1093/nar/22.6.1068&rft_dat=%3Cproquest_pubme%3E16807907%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-i389t-57c850135867dbf7917eb3286ca54af33b76b8eb5d2138d6558aeae3a233fbb23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16807907&rft_id=info:pmid/7908739&rfr_iscdi=true |